SkinBioTherapeutics Plc (LON:SBTX – Get Free Report) shares traded down 1.2% on Friday . The stock traded as low as GBX 21.06 ($0.26) and last traded at GBX 21.25 ($0.26). 92,171 shares were traded during mid-day trading, a decline of 79% from the average session volume of 433,214 shares. The stock had previously closed at GBX 21.50 ($0.27).
SkinBioTherapeutics Trading Down 1.2 %
The company has a market cap of £36.79 million, a price-to-earnings ratio of -1,062.50 and a beta of 2.17. The company has a current ratio of 1.77, a quick ratio of 10.01 and a debt-to-equity ratio of 9.03. The business’s 50 day moving average price is GBX 19.25 and its 200-day moving average price is GBX 16.90.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Featured Stories
- Five stocks we like better than SkinBioTherapeutics
- Are Stock Buybacks Good for the Average Investor?
- 52-week Low Names To Tip The Upside Scale In Your Favor
- What Investors Need to Know to Beat the Market
- KB Home Price Weakness is a Signal to Buy this Cash Machine
- Profitably Trade Stocks at 52-Week Highs
- Analysts Went All In On These Computer Stocks, Save Your Spot
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
